Nelson RH. Hyperlipidemia as a risk factor for cardiovascular disease. Prim Care. 2013;40:195–211.
Article
PubMed
Google Scholar
Sauer WH, Berlin JA, Kimmel SE. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation. 2001;104:1894–8.
Article
PubMed
CAS
Google Scholar
Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med. 2004;66:802–13.
Article
PubMed
Google Scholar
Ong KL, Morris MJ, McClelland RL, Maniam J, Allison MA, Rye KA. Lipids, lipoprotein distribution and depressive symptoms: the multi-ethnic study of atherosclerosis. Transl Psychiatry. 2016;6:e692.
Article
CAS
Google Scholar
Tedders SH, Fokong KD, McKenzie LE, Wesely C, Yu L, Zhang J. Low cholesterol is associated with depression among US household population. J Affect Disord. 2011;135:115–21.
Article
PubMed
CAS
Google Scholar
Maes M, Smith R, Christophe A, Vandoolaeghe E, Van Gastel A, Neels H, Demedts P, Wauters A, Meltzer HY. Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: relationship with immune-inflammatory markers. Acta Psychiatr Scand. 1997;95:212–21.
Article
PubMed
CAS
Google Scholar
Olusi SO, Fido AA. Serum lipid concentrations in patients with major depressive disorder. Biol Psychiatry. 1996;40:1128–31.
Article
PubMed
CAS
Google Scholar
Moreira FP, Jansen K, Cardoso TA, Mondin TC, Magalhães PVDS, Kapczinski F, Souza LDM, da Silva RA, Oses JP, Wiener CD. Metabolic syndrome in subjects with bipolar disorder and major depressive disorder in a current depressive episode: population-based study. Metabolic syndrome in current depressive episode J Psychiatr Res. 2017;92:119–23.
PubMed
Google Scholar
Nakao M, Yano E. Relationship between major depression and high serum cholesterol in Japanese men. Tohoku J Exp Med. 2004;204:273–87.
Article
PubMed
Google Scholar
Ledochowski M, Murr C, Sperner-Unterweger B, Neurauter G, Fuchs D. Association between increased serum cholesterol and signs of depressive mood. Clin Chem Lab Med. 2003;41:821–4.
Article
PubMed
CAS
Google Scholar
van Reedt Dortland AK, Giltay EJ, van Veen T, van Pelt J, Zitman FG, Penninx BW. Associations between serum lipids and major depressive disorder: results from the Netherlands study of depression and anxiety (NESDA). J Clin Psychiatry. 2010;71:729–36.
Article
PubMed
CAS
Google Scholar
Beydoun MA, Beydoun HA, Dore GA, Fanelli-Kuczmarski MT, Evans MK, Zonderman AB. Total serum cholesterol, atherogenic indices and their longitudinal association with depressive symptoms among US adults. Transl Psychiatry. 2015;5:e518.
Article
PubMed
PubMed Central
CAS
Google Scholar
Shao TN, Yin GZ, Yin XL, Wu JQ, Du XD, Zhu HL, Liu JH, Wang XQ, Xu DW, Tang WJ, Hui L. Elevated triglyceride levels are associated with cognitive impairments among patients with major depressive disorder. Compr Psychiatry. 2017;75:103–9.
Article
PubMed
Google Scholar
Steer RA, Ball R, Ranieri WF, Beck AT. Dimensions of the Beck depression inventory-II in clinically depressed outpatients. J Clin Psychol. 1999;55:117–28.
Article
PubMed
CAS
Google Scholar
Beck AT, Steer RA, Brown GK. Manual for the Beck depression inventory-II. San Antonio, TX: Psychological Corporation; 1996.
Google Scholar
Nunes SO, Piccoli de Melo LG, Pizzo de Castro MR, Barboso DS, Vargas HO, Berk M, Maes M. Atherogenic index of plasma and atherogenic coefficient are increased in major depression and bipolar disorder, especially when comorbid with tobacco use disorder. J Affect Disord. 2015;172:55–62.
Article
PubMed
CAS
Google Scholar
Aijänseppä S, Kivinen P, Helkala EL, Kivelä SL, Tuomilehto J, Nissinen A. Serum cholesterol and depressive symptoms in elderly Finnish men. Int J Geriatr Psychiatry. 2002;17:629–34.
Article
PubMed
Google Scholar
Oh J, Kim TS. Serum lipid levels in depression and suicidality: the Korea National Health and nutrition examination survey (KNHANES) 2014. J Affect Disord. 2017;213:51–8.
Article
PubMed
CAS
Google Scholar
Elovainio M, Pulkki-Råback L, Kivimäki M, Jokela M, Viikari J, Raitakari OT, Telama R, Keltikangas-Järvinen L. Lipid trajectories as predictors of depressive symptoms: the young Finns study. Health Psychol. 2010;29:237–45.
Article
PubMed
PubMed Central
Google Scholar
Atlantis E, Lange K, Goldney RD, Martin S, Haren MT, Taylor A, O’Loughlin PD, Marshall V, Tilley W, Wittert GA. Specific medical conditions associated with clinically depressive symptoms in men. Soc Psychiatry Psychiatr Epidemiol. 2011;46:1303–12.
Article
PubMed
Google Scholar
Lemche AV, Chaban OS, Lemche E. Depression contributing to dyslipidemic cardiovascular risk in the metabolic syndrome. J Endocrinol Investig. 2017;40:539–46.
Article
CAS
Google Scholar
Goldston K, Baillie AJ. Depression and coronary heart disease: a review of the epidemiological evidence, explanatory mechanisms and management approaches. Clin Psychol Rev. 2008;28:288–306.
Article
PubMed
Google Scholar
Xu C, He J, Jiang H, Zu L, Zhai W, Pu S, Xu G. Direct effect of glucocorticoids on lipolysis in adipocytes. Mol Endocrinol. 2009;23:1161–70.
Article
PubMed
PubMed Central
CAS
Google Scholar
Virtanen M, Ferrie JE, Akbaraly T, Tabak A, Jokela M, Ebmeier KP, Singh-Manoux A, Kivimäki M. Metabolic syndrome and symptom resolution in depression: a 5-year follow-up of older adults. J Clin Psychiatry. 2017;78:e1–7.
Article
PubMed
Google Scholar
Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet. 2014;384:626–35.
Article
PubMed
CAS
Google Scholar
Welty FK. How do elevated triglycerides and low HDL-cholesterol affect inflammation and atherothrombosis? Curr Cardiol Rep. 2013;15:400.
Article
PubMed
PubMed Central
Google Scholar